Kato K - Search Results

1

[Phase I / II study of XELOX plus bevacizumab in Japanese patients with metastatic colorectal cancer(JO19380)].

Sato A, Doi T, Boku N, Kato K, Komatsu Y, Yamaguchi K, Muro K, Hamamoto Y, Koizumi W, Mizunuma N, Takiuchi H. Sato A, et al. Among authors: kato k. Gan To Kagaku Ryoho. 2011 Apr;38(4):561-9. Gan To Kagaku Ryoho. 2011. PMID: 21498982 Clinical Trial. Japanese.

2

Feasibility study of ambulatory continuous infusion of 5-fluorouracil followed by cisplatin through hepatic artery for metastatic colorectal cancer.

Qin B, Kato K, Mitsugi K, Nakamura M, Tanaka R, Baba E, Ariyama H, Kuroiwa T, Harada M, Nakano S. Qin B, et al. Among authors: kato k. Cancer Chemother Pharmacol. 2006 Jan;57(1):114-9. doi: 10.1007/s00280-005-0021-8. Epub 2005 Nov 5. Cancer Chemother Pharmacol. 2006. PMID: 16001177

3

[Neoadjuvant therapy for esophageal cancer - indication and efficacy].

Kato K, Hamaguchi T, Yamada Y, Shirao K, Shimada Y. Kato K, et al. Gan To Kagaku Ryoho. 2007 Oct;34(10):1543-8. Gan To Kagaku Ryoho. 2007. PMID: 17940369 Review. Japanese.

4

Synergistic antitumor activity of the novel SN-38-incorporating polymeric micelles, NK012, combined with 5-fluorouracil in a mouse model of colorectal cancer, as compared with that of irinotecan plus 5-fluorouracil.

Nakajima TE, Yasunaga M, Kano Y, Koizumi F, Kato K, Hamaguchi T, Yamada Y, Shirao K, Shimada Y, Matsumura Y. Nakajima TE, et al. Among authors: kato k. Int J Cancer. 2008 May 1;122(9):2148-53. doi: 10.1002/ijc.23381. Int J Cancer. 2008. PMID: 18196580

5

A phase I trial of 5-fluorouracil with cisplatin and concurrent standard-dose radiotherapy in Japanese patients with stage II/III esophageal cancer.

Nakajima TE, Ura T, Ito Y, Kato K, Minashi K, Nihei K, Hironaka S, Boku N, Kagami Y, Muro K. Nakajima TE, et al. Among authors: kato k. Jpn J Clin Oncol. 2009 Jan;39(1):37-42. doi: 10.1093/jjco/hyn125. Jpn J Clin Oncol. 2009. PMID: 19103671 Clinical Trial.

6

A phase I escalating single-dose and weekly fixed-dose study of cetuximab pharmacokinetics in Japanese patients with solid tumors.

Shirao K, Yoshino T, Boku N, Kato K, Hamaguchi T, Yasui H, Yamamoto N, Tanigawara Y, Nolting A, Yoshino S. Shirao K, et al. Among authors: kato k. Cancer Chemother Pharmacol. 2009 Aug;64(3):557-64. doi: 10.1007/s00280-008-0904-6. Epub 2009 Jan 24. Cancer Chemother Pharmacol. 2009. PMID: 19169687 Clinical Trial.

7

Phase I study of the sequential administration of S-1 and cisplatin for metastatic gastric cancer.

Baba E, Fujishima H, Kusaba H, Esaki T, Ariyama H, Kato K, Tanaka R, Mitsugi K, Shibata Y, Harada M, Nakano S. Baba E, et al. Among authors: kato k. Anticancer Res. 2009 May;29(5):1727-32. Anticancer Res. 2009. PMID: 19443394 Free article. Clinical Trial.

8

Genetic polymorphisms of copper- and platinum drug-efflux transporters ATP7A and ATP7B in Japanese cancer patients.

Fukushima-Uesaka H, Saito Y, Maekawa K, Kurose K, Sugiyama E, Katori N, Kaniwa N, Hasegawa R, Hamaguchi T, Eguchi-Nakajima T, Kato K, Yamada Y, Shimada Y, Yoshida T, Yamamoto N, Nokihara H, Kunitoh H, Ohe Y, Tamura T, Ura T, Saito M, Muro K, Doi T, Fuse N, Yoshino T, Ohtsu A, Saijo N, Matsumura Y, Okuda H, Sawada J. Fukushima-Uesaka H, et al. Among authors: kato k. Drug Metab Pharmacokinet. 2009;24(6):565-74. doi: 10.2133/dmpk.24.565. Drug Metab Pharmacokinet. 2009. PMID: 20045993 Free article.

9

Phase I/II study of capecitabine plus oxaliplatin (XELOX) plus bevacizumab as first-line therapy in Japanese patients with metastatic colorectal cancer.

Doi T, Boku N, Kato K, Komatsu Y, Yamaguchi K, Muro K, Hamamoto Y, Sato A, Koizumi W, Mizunuma N, Takiuchi H. Doi T, et al. Among authors: kato k. Jpn J Clin Oncol. 2010 Oct;40(10):913-20. doi: 10.1093/jjco/hyq069. Epub 2010 May 12. Jpn J Clin Oncol. 2010. PMID: 20462981 Free PMC article. Clinical Trial.

10

A phase II study of paclitaxel by weekly 1-h infusion for advanced or recurrent esophageal cancer in patients who had previously received platinum-based chemotherapy.

Kato K, Tahara M, Hironaka S, Muro K, Takiuchi H, Hamamoto Y, Imamoto H, Amano N, Seriu T. Kato K, et al. Cancer Chemother Pharmacol. 2011 Jun;67(6):1265-72. doi: 10.1007/s00280-010-1422-x. Epub 2010 Aug 12. Cancer Chemother Pharmacol. 2011. PMID: 20703479 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,925 results

Search Page

Filters